ABL Bio raises $80M in Korean IPO

ABL Bio Inc. (KOSDAQ:298380) raised W90 billion ($80 million) through the sale of 6 million shares at W15,000 in an IPO in South Korea. The offering values the company at W668.8 billion ($594.4 million).

In November, ABL Bio had proposed to sell 6 million shares at W13,000-W17,000...